Google updated the documentation for the Google-Extended user agent, which publishers can use to control whether Google Gemini and Vertex use their data for training purposes or for grounding AI ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Solar financing platform Metafin on Tuesday said it raised $10 million in a Series A funding round led by Vertex Ventures Southeast Asia and India. The round, a mix of equity and debt, also saw ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Three people with type 1 diabetes who received Vertex Pharma’s islet cell therapy VX-880 have been able to come off insulin altogether within a year, raising the prospect of a life without ...

The study highlights Juncell Therapeutics' breakthroughs in TIL process development, demonstrating that its proprietary feeder-free system can generate robust, functional TILs from both "hot" and ...

Rats not only consume substantial amounts of seed but also cause damage to feeders and may even deter the very birds you wish to attract. However, Green suggests that there are four natural ...

Rod James covers private equity for The Wall Street Journal. He is particularly interested in matters related to limited partners, fundraising and the secondary market. Prior to the Journal, he ...

and hear about exciting investment opportunities.

We're always interested in hearing about news in our community. Let us know what's going on!